Italy-Belgium Bilateral Trade Analysis 2023

Complete trade statistics: $47.29B total volume โ€ขItaly deficit: $7.41B

Italy โ†’ Belgium

$19.94B

Exports (2023)

Belgium โ†’ Italy

$27.35B

Imports (2023)

Trade Balance

$7.41B

Deficit for Italy

Total Trade

$47.29B

Combined Volume

Trade Flow Visualization

Direct trade relationship between Italy and Belgium. Green line shows exports from Italy, red line shows imports.

Detailed Product Trade Analysis

Comprehensive breakdown of trade flows by product category, revealing the specialized nature of the Italy-Belgium commercial relationship and competitive positioning in global markets.

Italy โ†’ Belgium Exports

$19.94B
2023 Total

Export Market Intelligence

Product Diversity:
Highly Diversified
Market Share:
22.2% top product
1Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$4.43B
22.2% of exports
2Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale
$949.87M
4.8% of exports
3Vaccines: for human medicine
$726.45M
3.6% of exports
4Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale
$482.17M
2.4% of exports
5Petroleum oils and oils from bituminous minerals, not crude: preparations n.e.c. containing by weight 70% or more of petroleum oils or oils from bituminous minerals: these being the basic constituents of the preparations: waste oils
$373.71M
1.9% of exports
6Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions
$335.10M
1.7% of exports
7Vehicles: with only spark-ignition internal combustion reciprocating piston engine, cylinder capacity over 1000 but not over 1500cc
$253.51M
1.3% of exports
8Vehicle parts and accessories: n.e.c. in heading no. 8708
$233.24M
1.2% of exports
9Metals: gold, non-monetary, unwrought (but not powder)
$184.60M
0.9% of exports
10Vehicles: compression-ignition internal combustion piston engine (diesel or semi-diesel), for transport of goods, (of a gvw not exceeding 5 tonnes), n.e.c. in item no 8704.1
$157.87M
0.8% of exports

๐ŸŽฏ Strategic Export Focus

Italy's export portfolio to Belgium demonstrates strong diversification across multiple sectors, with medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale representing a key competitive advantage in this bilateral market.

Belgium โ†’ Italy Imports

$27.35B
2023 Total

Import Dependency Profile

Supply Diversity:
Well Diversified
Critical Imports:
12.3% concentration
1Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$3.35B
12.3% of imports
2Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
$1.53B
5.6% of imports
3Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934
$1.05B
3.8% of imports
4Diamonds: non-industrial, (other than unworked or simply sawn, cleaved or bruted), but not mounted or set
$476.21M
1.7% of imports
5Vehicles: with only compression-ignition internal combustion piston engine (diesel or semi-diesel), cylinder capacity over 1500 but not over 2500cc
$456.34M
1.7% of imports
6Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale
$327.19M
1.2% of imports
7Petroleum oils and oils from bituminous minerals, not crude: preparations n.e.c. containing by weight 70% or more of petroleum oils or oils from bituminous minerals: these being the basic constituents of the preparations: waste oils
$324.43M
1.2% of imports
8Sports footwear: tennis shoes, basketball shoes, gym shoes, training shoes and the like, with outer soles of rubber or plastics and uppers of textile materials
$316.69M
1.2% of imports
9Steroidal hormones, their derivatives and structural analogues: other than cortisone, hydrocortisone, prednisone (dehydrocortisone), prednisolone (dehydrohydrocortisone), halogenated derivatives of corticosteroidal hormones, oestrogen and progestogens
$309.04M
1.1% of imports
10Vehicles: with only electric motor for propulsion
$231.66M
0.8% of imports

๐Ÿ“ฆ Import Strategy Analysis

Italy's import pattern from Belgium reveals strategic sourcingin medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, highlighting complementary economic structures and potential supply chain optimization opportunities.

Competitive Trade Position Analysis

๐Ÿ†

Market Leadership

Italy demonstrates competitive strength in exportingmedicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale to Belgium, leveraging comparative advantages.

Export Leader in 20+ Categories
๐Ÿ”„

Trade Complementarity

The bilateral relationship showsstrongcomplementarity, with each country specializing in different sectors.

Highly Balanced
๐Ÿ“ˆ

Growth Potential

The $47.29B trade volume indicates substantial economic integration with room for expansion in emerging sectors.

Major Partnership

Executive Summary: Italy-Belgium Trade Relationship

Key Trade Highlights 2023

  • Total Trade Volume: $47.29 billionrepresenting a significant bilateral economic relationship
  • Trade Balance: Italy maintains a deficit of $7.41 billion
  • Export Focus: Italy's primary exports include medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale, vaccines: for human medicine
  • Import Dependencies: Key imports from Belgium include medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale, nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934

Strategic Trade Indicators

Trade IntensityHigh
Export DiversificationDiversified
Trade Balance HealthBalanced

๐Ÿ“ˆ Market Position: This bilateral trade relationship represents a significant global trade partnerships, with complementary economic strengths driving sustained commercial exchange.

Historical Trade Analysis & Economic Context

Trade Evolution Timeline

2019-2023: Recent Trends

Current trade volume of $47.29B represents the culmination of evolving bilateral commercial relationships, influenced by global supply chain shifts and changing economic priorities.

2015-2019: Growth Period

Sustained expansion in bilateral trade driven by complementary economic structures, with Italy leveraging its comparative advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.

2010-2015: Foundation Building

Establishment of modern trade frameworks and reduction of barriers, facilitating increased commercial exchange and investment flows between the two economies.

Pre-2010: Early Development

Initial stages of bilateral trade relationship development, with focus on traditional export-import patterns and gradual market integration.

Key Economic Drivers

1

Comparative Advantage

Italy's specialization in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail salecomplements Belgium's demand patterns, creating natural trade synergies.

2

Supply Chain Integration

Deep integration in global value chains has strengthened bilateral linkages, particularly in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.

3

Market Access & Trade Policy

Favorable trade agreements and market access conditions have facilitated the growth of this $47.29B bilateral relationship.

Trade Pattern Insights

Trade ComplementarityAsymmetric
Seasonal VariationsModerate
Product ConcentrationLow
Market DependencyModerate
๐Ÿ”ฎ

Trade Relationship Outlook

The $47.29B bilateral trade volume positions this relationship for continued growth, supported by technological advancement, evolving consumer preferences, and strengthening economic ties. Key opportunities lie in expanding cooperation in emerging sectors while managing potential supply chain vulnerabilities.

Economic Impact & Strategic Outlook

Economic Impact Assessment

๐Ÿ’ฐ

Trade Volume Impact

The $47.29 billion bilateral trade volume represents a significant economic factorfor both economies.

Economic Significance: High
๐Ÿญ

Industrial Integration

Trade flows in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale and medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale demonstrate deep industrial linkages and supply chain integration.

Supply Chain Integration: Diversified
โš–๏ธ

Trade Balance Effects

Italy's trade deficit of $7.41 billion impacts its overall economic position in this bilateral relationship.

Balance Impact: Well Balanced

Strategic Future Outlook

๐Ÿš€Growth Opportunities

Emerging Sectors
Technology transfer and innovation cooperation in medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale present expansion opportunities.
Market Diversification
Beyond current focus on medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, new product categories offer potential for trade expansion.

โš ๏ธRisk Factors

Supply Chain Vulnerabilities
Moderate concentration in key sectors requires monitoring
Market Competition
Global competition in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale may affect future market positioning.

๐ŸŽฏStrategic Recommendations

  • Strengthen cooperation in high-value sectors beyond current trade patterns
  • Develop alternative supply chains to reduce dependency risks
  • Explore joint ventures in emerging technology sectors
  • Enhance trade facilitation and reduce transaction costs

Market Position & Competitive Summary

The bilateral trade relationship between Italy and Belgium represents a total trade volume of $47.29 billion in 2023. This partnership demonstrates an unfavorable trade balance for Italy, with imports exceeding exportsby $7.41 billion.

Export Strengths

Italy's exports to Belgium total $19.94 billion, with competitive advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, representing $4.43B or22.2% of bilateral exports.

Import Dependencies

Imports from Belgium amount to $27.35 billion, highlighting economic interdependence in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, with Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale comprising12.3% of total imports.

The trade relationship reflects broader economic patterns and comparative advantages. The trade deficit indicates Italy's strategic sourcing from Belgium. This partnership is characterized by complementary trade flows, with each country specializing in different product categories based on their respective economic strengths, industrial capabilities, and position in global value chains.

Download Bilateral Trade Data

Access detailed trade data between Italy and Belgium in multiple formats.

Data Source: CEPII BACI (Base pour l'Analyse du Commerce International) โ€ข Last Updated: January 2025 โ€ข Coverage: 1995-2023